Media Contact
Amanda Galgay
Corporate Communications & Investor Relations
617-804-6659
amanda.galgay@peartherapeutics.com
Press Releases
- Pear Therapeutics Announces FDA Submission for Somryst™, a Prescription Digital Therapeutic for the Treatment of Adults With Chronic Insomnia and Depression July 18, 2019
- Pear Therapeutics to Participate in the Oppenheimer Summit for Emerging Biotechnology June 20, 2019
- Pear Therapeutics to Participate in the William Blair 39th Annual Growth Stock Conference June 4, 2019
- Pear Therapeutics to Present at the Jefferies Global Healthcare Conference May 30, 2019
- Pear Therapeutics to Present Data on reSET®, for the Treatment of Substance Use Disorder, and Pear-004, for the Treatment of Schizophrenia, at American Psychiatric Association Annual Meeting May 18, 2019
- Pear Therapeutics to Present at the Needham Emerging Technology Conference May 14, 2019